The cause and effect of gut microbiota in development of inflammatory disorders of the breast
- PMID: 37679821
- PMCID: PMC10483784
- DOI: 10.1186/s40001-023-01281-6
The cause and effect of gut microbiota in development of inflammatory disorders of the breast
Abstract
Background: Inflammatory disorders of the breast (IDB) damages the interests of women and children and hinders the progress of global health seriously. Several studies had offered clues between gut microbiota (GM) and inflammatory disorders of the breast (IDB). The gut-mammary gland axis also implied a possible contribution of the GM to IDB. However, the causality between them is still elusive.
Methods: The data of two-sample Mendelian randomization (MR) study related to the composition of GM (n = 18,340) and IDB (n = 177,446) were accessed from openly available genome-wide association studies (GWAS) database. As the major analytical method, inverse variance weighted (IVW) was introduced and several sensitive analytical methods were conducted to verify results.
Results: Inverse variance weighted revealed Eubacterium rectale group (OR = 1.87, 95% CI: 1.02-3.43, p = 4.20E-02), Olsenella (OR = 1.29, 95% CI: 1.02-1.64, p = 3.30E-02), Ruminiclostridium-6 (OR = 1.53, 95% CI: 1.08-2.14, p = 1.60E-02) had an anti-protective effect on IDB. Peptococcus (OR = 0.75, 95% CI: 0.60-0.94, p = 1.30E-02) had a protective effect on IDB. The results were credible through a series of test.
Conclusions: We revealed causality between IDB and GM taxa, exactly including Ruminiclostridium-6, Eubacterium rectale group, Olsenella and Peptococcus. These genera may become novel biomarkers and supply new viewpoint for probiotic treatment. However, these findings warrant further test owing to the insufficient evidences.
Keywords: Causal reasoning; Gut microbiota; Inflammatory disorders of the breast; Mendelian randomization study.
© 2023. BioMed Central Ltd., part of Springer Nature.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10483784/bin/40001_2023_1281_Fig1_HTML.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10483784/bin/40001_2023_1281_Fig2_HTML.gif)
![Fig. 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10483784/bin/40001_2023_1281_Fig3_HTML.gif)
Similar articles
-
Causal effects of gut microbiota on diabetic retinopathy: A Mendelian randomization study.Front Immunol. 2022 Sep 8;13:930318. doi: 10.3389/fimmu.2022.930318. eCollection 2022. Front Immunol. 2022. PMID: 36159877 Free PMC article.
-
Causal effects between gut microbiota and IgA nephropathy: a bidirectional Mendelian randomization study.Front Cell Infect Microbiol. 2023 May 2;13:1171517. doi: 10.3389/fcimb.2023.1171517. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37201114 Free PMC article.
-
Causal association between gut microbiota and intrahepatic cholestasis of pregnancy: mendelian randomization study.BMC Pregnancy Childbirth. 2023 Aug 5;23(1):568. doi: 10.1186/s12884-023-05889-8. BMC Pregnancy Childbirth. 2023. PMID: 37543573 Free PMC article.
-
Causal effects of gut microbiota on the risk of chronic kidney disease: a Mendelian randomization study.Front Cell Infect Microbiol. 2023 Mar 31;13:1142140. doi: 10.3389/fcimb.2023.1142140. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37065213 Free PMC article.
-
Identification of host gene-microbiome associations in colorectal cancer patients using mendelian randomization.J Transl Med. 2023 Aug 10;21(1):535. doi: 10.1186/s12967-023-04335-9. J Transl Med. 2023. PMID: 37563724 Free PMC article.
References
-
- Blackmon MM, Nguyen H, Mukherji P. Acute mastitis. StatPearls, Treasure Island (FL): StatPearls Publishing; 2023. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials